Malignancy development in lung transplant patients

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2316-2317

  Parada, M T ^a   Sepulveda C ^a   Alba, A ^a   Salas, A ^b  

^a CLÍNICA LAS CONDES   (Chile)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; EVEROLIMUS; STEROID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; LUNG ADENOCARCINOMA; LUNG TRANSPLANTATION; LYMPHOMA; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIPLE MYELOMA; PLEURA DISEASE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RETROSPECTIVE STUDY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; T CELL LYMPHOMA;

CHILE; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051685001     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.003     Document Type: Article

References (17)

1. J. Buell, T. Gross, and S. Woodle Malignancy after transplantation Transplantation 80 2005 S254
2. Y. Zafar, D. Howell, and J. Gockerman Malignancy after solid organ transplantation: an overview Oncologist 13 2008 769
3. G. Opelz, and B. Dohler Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2003 222
4. A. Amital, D. Shitrit, and Y. Raviv Development of malignancy following lung transplantation Transplantation 81 2006 547
5. J. Christie, L. Edwards, and P. Aurora The registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heart-lung transplantation report2009 J Heart Lung Transplant 28 2009 1031
6. S. Euvrard, J. Kanitakis, and A. Claudy Skin cancers after organ transplantation N Engl J Med 348 2003 1681
7. S. Ingvar, K. Ekström, and K. Smedby Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma Nephrol Dial Transplant 25 2010 2764
8. J. Dantal, and J.P. Soulillou Immunosuppressive drugs and the risk of cancer after organ transplantation N Engl J Med 352 2005 1371
9. N. Shiba, M.C. Chan, and B.W. Kwok Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience J Heart Lung Transplant 23 2004 155
10. M. Hojo, T. Morimoto, and M. Maluccio Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature 397 1999 530
11. K. Wang, H. Zhang, and Y. Li Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review Transplant Proc 36 2004 2068
12. V.R. Dharnidharka, P.L. Ho, and D.M. Stablein Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study Pediatr Transplant 6 2002 396
13. T. Engl, J. Makarevic, and B. Relja Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy BMC Cancer 5 2005 4
14. Y. Yakupoglu, R. Knight, and S. Katz Low incidence of malignancy among sirolimus-cyclosporine treated transplant recipients Am J Transplant 3 suppl 5 2004 187
15. J.F. Trotter Sirolimus in liver transplantation Transplant Proc 35 2003 193S
16. P. Ramalingam, L. Rybicki, and M.D. Smith Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience Mod Pathol 15 2002 647
17. R. Shroff, and L. Rees The post-transplant lymphoproliferative disordera literature review Pediatr Nephrol 19 2004 369